ZHANG Shi-qian, HUANG Wen-qian.. Circulating tumor DNA and liquid biopsy in early screening of gynecologic tumor.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2016040107.
[1] Traver S，Assou S，Scalici E，et al. Cell-free nucleic acids as non-invasive biomarkers of gynecological cancers，ovarian，endometrial and obstetric disorders and fetal aneuploidy[J].Hum Reprod Update，2014，20：905-923.[2] Leon SA，Shapiro B，Sklaroff DM，et al. Free DNA in the serum of cancer patients and the effect of therapy[J].Cancer Res，1977，37：646-650.[3] Snyder MW，Kircher M，Hill AJ，et al.Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin[J].Cell，2016，164：57-68.[4] Murtaza M，Dawson SJ，Tsui DW，et al.Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA[J].Nature，2013，497：108-112.[5] Kamat AA，Bischoff FZ，Dang D，et al.Circulating cell-free DNA：a novel biomarker for response to therapy in ovarian carcinoma[J].Cancer Biol Ther，2006，5：1369-1374.[6] Gloss BS，Samimi G.Epigenetic biomarkers in epithelial ovarian cancer[J].Cancer Lett，2014，342：257-263.[7] de Caceres I，Battagli C，Esteller M，et al.Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum，plasma，and peritoneal fluid from ovarian cancer patients[J].Cancer Res，2004，64：6476-6481.[8] Zhang Q，Hu G，Yang Q，et al.A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA[J].Gynecol Oncol，2013，130：132-139.[9] Liggett TE，Melnikov A，Yi Q，et al.Distinctive DNA methylation patterns of cell-free plasma DNA in women with malignant ovarian tumors[J].Gynecol Oncol，2011，120：113-120.[10] Sathish N，Abraham P，Peedicayil A，et al.HPV DNA in plasma of patients with cervical carcinoma[J].J Clin Virol，2004，31(3)：204-209.[11] Jaberipour M，Samsami A，Sahraiian F，et al.Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer[J].Asian Pac J Cancer Prev，2011，12(1)：163-167.[12] Lai HC，Lin YW，Huang TH，et al.Identification of novel DNA methylation markers in cervical cancer[J].Int J Cancer，2008，123(1)：161-167.[13] Yang HJ，Liu VW，Wang Y，et al.Detection of hypermethylated genes in tumor and plasma of cervical cancer patients[J].Gynecol Oncol，2004，93(2)：435-440.[14] Widschwendter A，Müller HM，Fiegl H，et al.DNA methylation in serum and tumors of cervical cancer patients[J].Clin Cancer Res，2004，10(2)：565-571.[15] Tanaka H，Tsuda H，Nishimura S，et al.Role of circulating free alu DNA in endometrial cancer[J].Int J Gynecol Cancer，2012，22(1)：82-86.[16] Wittenberger T，Sleigh S，Reisel D，et al.DNA methylation markers for early detection of women's cancer：promise and challenges[J].Epigenomics，2014，6(3)：311-327.[17] The Lancet Oncology.Liquid cancer biopsy：the future of cancer detection?[J]. Lancet Oncol，2016，17(2)：123-129.（2016-02-23收稿）
